A single nucleotide polymorphism in exon 3 of the kallikrein 1 gene is associated with large but not small abdominal aortic aneurysm by Biros, Erik et al.
Accepted Manuscript
Title: A single nucleotide polymorphism in exon 3 of the
kallikrein 1 gene is associated with large but not small
abdominal aortic aneurysm
Authors: Erik Biros, Paul E. Norman, Philip J. Walker, Maria
Nataatmadja, Malcolm West, Jonathan Golledge
PII: S0021-9150(11)00359-5
DOI: doi:10.1016/j.atherosclerosis.2011.04.017
Reference: ATH 11966
To appear in: Atherosclerosis
Received date: 18-1-2011
Revised date: 12-4-2011
Accepted date: 12-4-2011
Please cite this article as: Biros E, Norman PE, Walker PJ, Nataatmadja M, West M,
Golledge J, A single nucleotide polymorphism in exon 3 of the kallikrein 1 gene is
associated with large but not small abdominal aortic aneurysm, Atherosclerosis (2010),
doi:10.1016/j.atherosclerosis.2011.04.017
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
Page 1 of 23
Ac
ce
pte
d M
an
us
cri
pt
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
A single nucleotide polymorphism in exon 3 of the kallikrein 1 gene is associated with 
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ABSTRACT 
Objective: Abdominal aortic aneurysm (AAA) is a late onset degenerative condition with an 
inherited component thought to be due to multiple risk alleles. A locus on chromosomes 
19q13 has been previously associated with AAA. The gene encoding kallikrein 1 (KLK1) is 
located on chromosome 19q13 and the single nucleotide polymorphism (SNP) rs5516 has 
been previously shown to lead to structural changes in the KLK1 transcription regulatory 
region. The aim of this study was to investigate whether rs5516 was associated with AAA 
and aortic diameter. 
Methods: We performed a case-control study on two independent subject groups from 
Western Australia (n=1304) and Queensland (n=325) of which 609 and 225 had an AAA, 
respectively. In addition we analysed RNA extracted from abdominal aortic biopsies from 12 
patients undergoing AAA surgery and 6 organ donors. 
Results: After adjusting for other risk factors the G allele of the rs5516 polymorphism was 
associated with large but not small AAA using a dominant model in the Western Australian 
men and a recessive model in Queensland subjects. In subjects with large AAA the G allele 
was associated with aortic diameter. The short splice variant of KLK1 was upregulated within 
AAA compared to control biopsies. 
Conclusion: This study suggests that a genetic polymorphism in KLK1 may contribute to the 
risk of developing later stage AAA. 
 
Keywords 
Abdominal aortic aneurysm; kallikrein 1, splice variants 
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INTRODUCTION 
Screening studies indicate that ~ 5% of men aged > 60 years have an abdominal aortic 
aneurysm (AAA) [1]. Important risk factors for AAA include age, smoking, coronary heart 
disease, hypertension and family history [2]. Subjects with a first degree relative with a 
history of AAA have a approximately 2-fold increased risk of developing the condition [3]. 
Genome-wide screening of patients with a family history of AAA using affected relative 
pairs suggested two linkage regions on chromosomes 19q13 and 4q31 with a logarithm of 
odds (LOD) scores of approximately 5 and 4, respectively [4]. These two genomic regions 
have been termed AAA1 and AAA2 loci in the Online Mendelian Inheritance in Man 
(OMIM) database [5]. Both AAA susceptibility loci were further confirmed using DNA 
linkage analyses approaches in different populations [6, 7]. One of the genes located within 
the AAA1 locus encodes kallikrein 1 (KLK1) [8]. Kallikrein 1 is a serine protease which 
converts low molecular weight kininogen to Lys-bradykinin, a peptide which has a range of 
biological actions relevant to AAA such as promotion of inflammation [9, 10, 11]. There are 
two chief receptors stimulated by kinins, namely B1 and B2. Deficiency of the B1 kinin 
receptor has been associated with increased risk of AAA development in a mouse model in 
which aneurysm was induced by angiotensin II infusion [12]. Single nucleotide 
polymorphisms (SNPs) in KLK1 have previously been associated with intracranial aneurysm 
[13] but not been assessed for association with AAA.  
We selected rs5516 (g.23591691C>G) located within exon 3 of the KLK1 gene for 
study on the basis of its involvement in exonic splicing enhancer (ESE) activity [14]. During 
this process a mature mRNA is formed and sequence variations within ESE sites may alter 
the relative expression of mRNA isoforms i.e. the relative types of splice variants [15]. The 
KLK1 gene has been shown to express two alternatively spliced variants: intron 3 spliced 
(short) and intron 3 retained (long) isoforms [16]. The aim of the present study was to assess 
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the association of rs5516 SNP with AAA within two separate case-control series imaged for 
AAA. We also postulated that alternative splicing variants of KLK1 could be associated with 
AAA and sought evidence to support this theory within aortic biopsies. 
 
MATERIAL AND METHODS 
Patients 
In order to assess the association of the rs5516 SNP with AAA we examined two 
case-control groups: a) 609 men with AAA and 695 without AAA from the Western 
Australian Health In Men Study (HIMS) [17, 18]; b) 225 patients with AAA and 100 subjects 
who had symptoms of lower limb athero-thrombosis but no AAA from Australia's north east 
state of Queensland [19, 20]. HIMS subjects had undergone abdominal ultrasound, while 
Queensland subjects were imaged by computed tomography angiography (CTA). The 
reproducibility of ultrasound was assessed during subject recruitment and 95% confidence 
intervals were < 3mm [17]. Maximum axial infrarenal aortic diameter in Queensland subjects 
was assessed using the CTA viewer function on the Philips workstation (MxView 
Visualization Workstation Software, Philips Electronics Australia). Maximum diameter was 
recorded in millimeters to the nearest 0.1 mm [19, 20]. Small AAAs were defined as a 
maximum infrarenal aortic diameter measuring 30 to 49mm and large AAAs as those ≥ 
50mm. Controls had maximum infrarenal aortic diameter ≤ 25mm. The definitions of risk 
factors such as hypertension, dyslipidemia, diabetes, coronary heart disease (CHD) and 
smoking were as previously described [21]. 
Aortic wall biopsies were collected in RNAlater
®
 solution (Ambion) from a group of 
12 men undergoing open AAA repair and 6 organ donors in Queensland, Australia. AAA 
samples were obtained from the body of the aneurysm (site of maximum dilatation). Donor 
abdominal aortic tissues were used as controls. Total RNA was extracted using RNeasy
®
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Mini Kit (Qiagen) according to manufacturer’s instructions. Ethical approval was granted 
from the relevant committees. 
Genotyping 
The human kallikrein 1 is a highly polymorphic gene with more than 120 single 
nucleotide polymorphisms (SNPs) including seven missense variations [22]. Among these 
SNPs rs5516 was selected for genotyping because of its high level of heterozygosity (0.464) 
in Caucasians [22] allowing detection of all three possible genotypes in relatively small 
numbers of individuals. This SNP has been reported to modify the gene expression regulatory 
sequences in exon 3 of the KLK1 gene. Genotyping of the HIMS and Queensland subjects 
was carried out at the Australian Genome Research Facility, University of Queensland, using 
the Sequenom’s MassARRAY system that utilizes a homogenous MassExtend (hME – single 
base extension) reaction termed iPLEX GOLD. Genotype calls were made using 
SpectroTYPER
TM
 RT software (Sequenom Inc., San Diego, CA, USA). Genotyping 
efficiency of rs5516 was 97% and 98% for HIMS and Queensland groups, respectively. 
Tissue expression 
Quantitative real-time PCR (qPCR) was performed for both short and long splice 
variants of the KLK1 mRNA. The relative expression of these isoforms in each sample was 
calculated by using the concentration-Ct-standard curve method and normalized using the 
average expression of GAPDH for each sample. GAPDH was chosen as the “housekeeping” 
gene since analyses showed its expression to be similar in aortic biopsies from AAA patients 
and organ donors. The QuantiTect SYBR
®
 Green one-step RT-PCR Kit (Qiagen) was used 
according to the manufacturer’s instructions with 100ng of total RNA as template. SYBR® 
Green PCR primers were designed using the RASE (Real-time PCR Annotation of Splicing 
Events) tool [23] for both KLK1 short variant (5’-ATGCTGTGAAGGTCGTGGAGTT-3’ 
and 5’- CACTGGAGATCATCTGGAAATGAGAAA-3’, reference sequence NM_002257) 
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and KLK1 long variant (5’-GGTTCGTAGTCTCATTTCC-3’ and 5’-
AAGTCTGTCACCTTCTGG-3’, reference sequence AY429508). Qiagen’s QT01192646 
QuantiTect
®
 Primer Assay was used to assess GAPDH expression. 
Statistical analyses 
Univariate association of continuous and nominal covariates with AAA was examined 
by Mann–Whitney U test and Fisher exact test, respectively. Our primary binary outcome 
was the presence of small or large AAAs. The secondary quantitative outcome was maximum 
infrarenal aortic diameter. Logistic regression was used to model the effects of multiple 
covariates on binary and quantitative outcomes under dominant and recessive models. 
Hypertension, coronary heart disease, dyslipidemia, smoking and gender (Queensland group 
only), in addition to rs5516 genotype, were examined for inclusion in the model. Forward 
stepwise variable selection procedures were performed where only significant covariates 
were retained in the models. A dominant model measured differences between rs5516 CC 
homozygotes and G allele carriers, while a recessive model compared GG homozygotes with 
C allele carriers. All computations were undertaken using SimHap v1.0.2 [24]. Hardy-
Weinberg equilibrium was tested using HPlus v3.1 [25]. Results from the HIMS and 
Queensland groups were meta-analyzed by Comprehensive Meta Analysis v2 (Biostat, Inc.). 
Combined odds ratio (OR) and standardized mean difference (SMD) in maximum aortic 
diameter were determined using fixed effects models. SMD represents the difference in 
means between two groups divided by the pooled standard deviation of the measurements 
[26]. Mann–Whitney U test using the PASW Statistics 18 Release 18.0.0 package was 
performed to identify differences between KLK1 short and long splice variants expression 
levels. Statistical significance was defined at the conventional 5% level. 
 
 
Page 7 of 23
Ac
ce
pte
d M
an
us
cri
pt
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Power calculation 
The available sample sizes had an 80% power to detect an effect size (OR) of 
approximately 1.5 and 2.3 for the association of the risk allele with small AAA in the HIMS 
and Queensland subjects, respectively. The available sample sizes had an 80% power to 
detect an OR of approximately 4.2 and 3.0 for the association of the risk allele with large 
AAA in the HIMS and Queensland subjects, respectively. Alpha was assumed to be 0.05. 
Calculations were performed by using the PS: Power and Sample Size Calculation v3.0 
software [27]. 
 
RESULTS 
HIMS subjects 
Genotyping was carried out in 1304 HIMS subjects of whom 19 (2%) had large and 
590 (45%) had small AAAs (Table 1). Genotype distribution of rs5516 passed testing for 
Hardy-Weinberg equilibrium (P=0.1178) in controls and therefore was assessed for 
association with AAA and aortic diameter. Multivariate analysis showed that the rs5516 
minor (G) allele was significantly associated with large but not small AAA with OR=2.97, 
P=0.044, under a dominant model (Table 2). Rs5516 was also significantly associated with 
aortic diameter in HIMS men with large AAA (Table 3). The effect was seen under a 
recessive model where minor allele GG homozygotes had significantly larger mean aortic 
diameter (about 19mm greater, P=0.002) compared with C allele carriers. 
Queensland subjects 
Genotyping was performed on 325 Queensland subject of whom 60 (18%) had large 
AAAs, 165 (51%) had small AAAs, and 100 (31%) no AAAs (Table 1). The genotype 
frequencies of rs5516 were consistent with Hardy-Weinberg equilibrium (P=0.5128) in 
controls and therefore we assessed the association of rs5516 with AAA and aortic diameter. 
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There was a significant association between GG genotype and large AAA (OR=4.20, 
P=0.024, Table 2). Rs5516 was not associated with small AAAs. Rs5516 was also 
significantly associated with aortic diameter in Queensland subjects with large AAA (Table 
3). Individuals with GG genotype had significantly larger mean aortic diameter (about 11mm 
greater, P=0.009) compared with C allele carriers. 
Meta-analysis 
Data was combined from both case-control studies under dominant and recessive models 
(Table 4). Under a recessive model the G allele was associated with large AAA at borderline 
significance (OR 2.4, P=0.056). Under a similar recessive model the G allele was strongly 
associated with bigger diameter large AAAs (standardized mean difference 0.59, P<0.001) 
(Table 4). 
Aortic expression of KLK1 splice variants 
The relative expression of both short and long variants of KLK1 mRNA was markedly 
increased in biopsies from AAAs compared to those from normal abdominal aortas (Table 5). 
The ratio of short and long mRNAs in the aortic biopsies from the two subject groups was 
also markedly different. In subjects with AAA the short variant of KLK1 mRNA was 
expressed 5-fold more commonly than the long variant. In contrast in the biopsies from organ 
donors the long variant of KLK1 mRNA was expressed 10-fold more commonly than the 
short variant (Table 5).  
 
 
 
DISCUSSION 
The main findings of this study were that the G allele of KLK1 rs5516 polymorphism 
was associated with large but not small AAAs after adjusting for other risk factors in both 
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groups examined. In the patients with large AAAs the G allele was also associated with the 
size of the AAA. These findings suggest that changes in KLK1 activity could be relevant to 
later stage AAA progression. 
Previous studies have suggested that aortic diameter is an important predictor of the 
natural history for rupture in AAAs. For small AAAs (40-55mm) it is estimated that the 
rupture rate is approximately 1% per year, while for AAAs of 70mm or more the rupture rate 
is estimated to be approximately 30% per year [28, 29]. It has been suggested that the 
evolution of AAA occurs in a number of stages including initiation, enlargement and rupture. 
Progressive aortic wall dilatation is associated with cycles of extracellular matrix degradation 
[30] and inflammation, involving proteolytic enzymes produced by invading inflammatory 
cells [31, 2]. Our findings suggest a role of the KLK1 gene in large but not small AAA. 
Larger AAAs have some distinct features, such as a greater volume of intraluminal thrombus 
which contains cytokines, neutrophils, proteolytic enzymes and platelets [32, 33]. Kininogen 
has been demonstrated to bind to the surface of the cells contained within AAA thrombus, 
such as platelets, which bring substrate for tissue kallikrein expressed by infiltrating 
inflammatory cells, such as neutrophils. Kininogen has also been demonstrated within 
endothelial cells prevalent in areas of neovascularisation typically found in the wall of AAA 
[34]. Kinins released by kallikrein can then promote further inflammation which is believed 
critical in AAA progression [11]. Inhibition of platelet aggregation limits AAA progression 
and neutrophil accumulation within a guinea pig to rat aortic transplant AAA model and 
could potentially act via changes in kinins [35]. 
Previous genome-wide screening studies suggested that a locus on chromosome 
19q13 was linked with AAA [4-7]. KLK1 is one of more than a hundred genes located in this 
region and has been examined in this study. A number of other genes encoded within this 
region could be associated with AAA. In a recent study, 615 tagging SNPs within 
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chromosome 19q13 that also included the KLK1 locus were assessed in 1024 Dutch subjects 
[36]. In this series, however, Baas and colleagues reported that none of these SNPs showed 
any evidence of association with AAA. A number of differences exist between the subjects 
examined in the study of Baas and colleagues and the current investigation. In the current 
study in the independent populations examined cases and controls were recruited in the same 
way, i.e. from out-patient vascular clinics in Queensland and by population screening in 
Western Australia. All subjects were imaged and similar risk factor data recorded. In contrast 
in the Dutch study the control group was mainly recruited separately from blood donors who 
did not undergo imaging and risk factor assessment and were generally much younger than 
the AAA cases. Some of these differences may explain the disparate results reported. 
The current study also provides preliminary evidence for an association of the short 
KLK1 splice variants with AAA. Splicing requires both a recognition site and regulatory 
sequences such as exonic splicing silencers (ESSs) and enhancers (ESEs) that regulate 
accurate splicing of the pre-mRNA into messenger RNA (mRNA). The KLK1 gene has two 
alternative transcripts due to the retention of its third intron [16]. These include a classical 
short variant and the long isoform in which intron 3 is retained. Both the short and long 
isoforms were upregulated in AAA biopsies however the short variant was expressed at 5-
fold greater levels. In contrast, in biopsies of organ donors, the predominant KLK1 isoform 
was the long form. It is possible that rs5516 influences the balance between splicing and 
retention of the KLK1 third intron, as this SNP is located within its ESE site. 
The current study has a number of limitations. We included well phenotyped 
individuals in which all subjects were imaged for AAA presence, however detailed imaging 
of coronary or cerebrovascular arteries was not performed. Risk factor information was 
collected by standardized questionnaires and adjusted for in the multivariate analyses. The 
sample sizes available were however relatively small, particularly with respect to the number 
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of subjects with large AAAs. The high odds ratios identified in this study are not typical of 
those expected for genetic risk alleles for multigenic complex diseases [4, 6, 7]. Previous 
studies for example have reported odds ratios for the association of a locus on chromosome 
9p21.3 with AAA of approximately 1.4 [37, 38]. Also our findings were not completely 
consistent in both groups assessed. In the HIMS subjects the association between rs5516 and 
large AAA was demonstrated in a dominant model, while in the Queensland subjects this 
association was only found using a recessive model. Further studies in other populations are 
required to confirm our findings. 
In conclusion, to our knowledge this is the first published report examining the 
association of a functional SNP in KLK1 gene with AAA. Our findings suggest that rs5516 is 
associated with large but not small AAA. The findings highlight the possibility that distinct 
genetic mechanisms may contribute to the risks of AAA initiation and progression. Further 
large studies are required to provide more definitive evidence. 
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Table 1: Characteristics of subjects undergoing KLK1 genotyping  
Subjects HIMS Queensland 
Characteristic Large AAA Small AAA No AAA Large AAA Small AAA No AAA 
Number 19 590 695 60 165 100 
Aortic diameter (mm) 58.7±9.9 35.4±4.83 21.2±1.9 60.5±11.8 38.5±5.5 19.9±3.2 
Women 0 0 0 7 (12%) 39 (24%) 36 (36%) 
Age (years) 73.2±4.4 73.3±4.4 73.1±4.4 72.7±6.2* 71.7±8.0* 65.4±10.3 
Hypertension 12 (63%)* 315 (53%)* 263 (38%) 40 (68%) 121 (73%) 68 (68%) 
Diabetes mellitus 1 (5%) 62 (11%)* 49 (7%) 10 (17%)* 31 (19%)* 35 (35%) 
Dyslipidemia 5 (26%) 265 (45%)* 231 (33%) 29 (49%) 114 (70%)* 53 (53%) 
Coronary heart disease 11 (58%)* 233 (40%)* 123 (18%) 35 (58%)* 93 (56%)* 37 (37%) 
Ever smoker 17 (89%)* 504 (85%)* 431 (62%) 45 (76%) 137 (83%) 74 (74%) 
Nominal variables are presented as numbers; continuous variables are presented as mean ± standard deviation. Continuous variables were 
compared between subjects with large or small AAA and controls using Mann Whitney U test (*p<0.05); Nominal variables were compared 
between subjects with large or small AAA and controls using Fisher exact test (*p<0.05). 
 
Page 18 of 23
Ac
ce
pte
d M
an
us
cri
pt 1  2  3  4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
Table 2: Multivariate association of rs5516 with AAA 
Group AAA Genotype 
N Dominant Model Recessive Model 
AAA No AAA OR 95% CI P AIC OR 95% CI P AIC 
HIMS 
Small AAA 
CC 291 341 - - - 
1440 
NS 
- - - 1439 
NS 
CG 242 279 
1.03 0.80-1.32 0.814 
GG 57 75 0.86 0.57-1.29 0.460 
Large AAA 
CC 5 341 - - - 
158 
0.032 
- - - 162 
NS 
CG 11 279 
2.97 1.03-8.58 0.044 
GG 3 75 1.31 0.36-4.77 0.687 
Queensland 
Small AAA 
CC 63 52 - - - 
339 
NS 
- - - 342 
NS 
CG 89 42 
1.70 1.01-2.87 0.047 
GG 13 6 1.65 0.59-4.64 0.340 
Large AAA 
CC 31 52 - - - 
202 
NS 
- - - 197 
0.019 
CG 20 42 
1.12 0.56-2.22 0.747 
GG 9 6 4.20 1.21-14.54 0.024 
N, number of individuals; CI, confidence intervals; AIC, Akaike's information criterion; NS, Non-significant model. 
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The association between rs5516 with AAA was adjusted for hypertension, coronary heart disease, dyslipidemia, and smoking in the HIMS group 
and for gender, hypertension, coronary heart disease, dyslipidemia and smoking in the Queensland group. 
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Table 3:  Multivariate association of rs5516 with aortic diameter 
Group Genotype Frequency 
Dominant Model Recessive Model 
Coefficient SE P Mean AIC Coefficient SE P Mean AIC 
HIMS 
Control 
CC 0.491 - - - 21.2 
2845 
NS 
- - - 21.2 2845 
NS 
CG 0.401 
0.0524 0.142 0.712 21.3 
GG 0.108 0.0306 0.228 0.894 21.2 
Small 
AAA 
CC 0.493 - - - 35.3 
3542 
NS 
- - - 35.3 3542 
NS 
CG 0.410 
0.0393 0.399 0.921  35.3 
GG 0.097 0.1470 0.678 0.828 35.4 
Large 
AAA 
CC 0.263 - - - 61.3 
150 
NS 
- - - 57.6 136 
0.0002 
CG 0.579 
-0.9267 5.967 0.879 60.4 
GG 0.158 19.2290 5.056 0.002 76.8 
Queensland 
Control 
CC 0.520 - - - 20.0 
491 
NS 
- - - 19.9 491 
NS 
CG 0.420 
-0.2468 0.577 0.670 19.8 
GG 0.060 0.1069 1.230 0.931 20.0 
Small CC 0.382 - - - 38.7 1042 - - - 38.5 1042 
Page 21 of 23
Ac
ce
pte
d M
an
us
cri
pt 1  2  3  4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
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41 
42 
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AAA CG 0.539 
-0.4273 0.900 0.636 38.3 
NS NS 
GG 0.079 -1.0990 1.624 0.499 37.4 
Large 
AAA 
CC 0.517 - - - 58.3 
467 
NS 
- - - 58.7 462 
0.0058 
CG 0.333 
4.4692 3.159 0.163 62.8 
GG 0.150 11.3066 4.184 0.009 70.0 
SE, standard error; Mean, mean aortic diameter in mm; AIC, Akaike's information criterion; NS, non-significant model. 
The association between rs5516 with aortic diameter was adjusted for hypertension, coronary heart disease, dyslipidemia and smoking in the 
HIMS group and for gender, hypertension, coronary heart disease, dyslipidemia and smoking in the Queensland group. 
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Table 4: Meta-analysis assessing the association of the G allele of rs5516 with large AAA and aortic diameter  
Group 
Dominant model Recessive model 
Large AAA Aortic diameter of large AAAs Large AAA Aortic diameter of large AAAs 
OR 95% CI P SMD SE 95% CI P OR 95% CI P SMD SE 95% CI P 
HIMS 2.97 1.03-8.58 0.044 -0.04 0.23 -0.49-0.42 0.877 1.31 0.36-4.77 0.687 0.88 0.23 0.43-1.34 <0.001 
Queensland 1.12 0.56-2.22 0.747 0.23 0.16 -0.09-0.55 0.158 4.20 1.21-14.54 0.024 0.44 0.17 0.12-0.77 0.008 
Combined 1.50 0.84-2.67 0.172 0.14 0.13 -0.12-0.41 0.288 2.40 0.98-5.88 0.056 0.59 0.14 0.33-0.85 <0.001 
OR, odds ratio; CI, 95% confidence intervals; SMD, standardized mean difference; SE, standard error. 
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Table 5: Relative expressions of KLK1 splice variants in 12 AAA and 6 control biopsies. 
KLK1 variant Sample N Median IQR P 
Short 
AAA 12 1.928 1.194-2.262 
 0.001 
No AAA 6 0.007 0.006-0.010 
Long 
AAA 12 0.238 0.132-0.793 
0.021 
No AAA 6 0.062 0.046-0.098 
Short to Long ratio 
AAA 12 5.110 3.224-16.140 
0.002 
No AAA 6 0.133 0.054-0.149 
N, number; IQR, interquartile range; P, two-sided P-value 
